Literature DB >> 21085923

Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation.

Chang-Hung Kuo1, Ying-Chin Ko, San-Nan Yang, Yu-Te Chu, Wei-Li Wang, Shau-Ku Huang, Huan-Nan Chen, Wan-Ju Wei, Yuh-Jyh Jong, Chih-Hsing Hung.   

Abstract

Chemokines play important roles in asthma. Prostaglandin I(2) (PGI(2)) analogue is recently suggested as a candidate for treating asthma. However, the effects of PGI(2) analogues on the expression of Th1- and Th2-related chemokines are unknown. To this end, we investigated the in vitro effects of PGI(2) analogues on the expression of Th1-related chemokine interferon-γ-inducible protein-10 (IP-10/CXCL10) and Th2-related chemokine macrophage-derived chemokine (MDC/CCL22) in human monocytes. The human monocytes were pretreated with iloprost and treprostinil before lipopolysaccharide (LPS) stimulation. IP-10 and MDC were measured by ELISA. Intracellular signaling was investigated by cyclic adenosine monophosphate (cAMP) assay, western blot and chromatin immunoprecipitation. PGI(2) analogues enhanced MDC, but suppressed IP-10 expression in LPS-stimulated monocytes. These effects were reversed by the I prostanoid (IP) receptor antagonist (CAY10449), peroxisomal proliferators-activated receptor (PPAR)-α antagonist (GW6741) and PPAR-γ antagonist (GW9662). PGI(2) analogues increased intracellular cAMP levels. Forskolin, an adenyl cyclase activator, conferred similar effects. PGI(2) analogue-enhanced MDC expression was reduced by nuclear factor (NF) κB inhibitor (BAY 117085) and mitogen-activated protein kinase (MAPK)-p38 inhibitor (SB203580). PGI(2) analogues up-regulated phospho-p65 and phospho-p38 but down-regulated phospho-ERK expression. Iloprost enhanced H3 acetylation in MDC promoter area and suppressed H3 acetylation, H3K4, and H3K36 trimethylation in IP-10 promoter area. PGI(2) analogues enhanced MDC expression via the I prostanoid-receptor-cAMP, PPAR-α and PPAR-γ, NFκB-p65, MAPK-p38-ATF2 pathways and increasing histone acetylation, and suppressed IP-10 expression via the IP-receptor-cAMP, PPAR-γ, MAPK-ERK-ELK1 pathways and inhibiting histone acetylation and trimethylation in LPS-stimulated monocytes. PGI(2) analogues may therefore increase Th2 recruitment and inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085923     DOI: 10.1007/s00109-010-0694-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  34 in total

Review 1.  Endotoxin-stimulated innate immunity: A contributing factor for asthma.

Authors:  C E Reed; D K Milton
Journal:  J Allergy Clin Immunol       Date:  2001-08       Impact factor: 10.793

2.  Expression and activity of histone deacetylases in human asthmatic airways.

Authors:  Kazuhiro Ito; Gaetano Caramori; Sam Lim; Tim Oates; K Fan Chung; Peter J Barnes; Ian M Adcock
Journal:  Am J Respir Crit Care Med       Date:  2002-08-01       Impact factor: 21.405

3.  Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.

Authors:  Lucie H Clapp; Paul Finney; Sally Turcato; Sandy Tran; Lewis J Rubin; Andrew Tinker
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

4.  Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities.

Authors:  David M Aronoff; Camila M Peres; Carlos H Serezani; Megan N Ballinger; Jennifer K Carstens; Nicole Coleman; Bethany B Moore; R Stokes Peebles; Lucia H Faccioli; Marc Peters-Golden
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

5.  Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma.

Authors:  T F Leung; G W K Wong; F W S Ko; C W K Lam; T F Fok
Journal:  Clin Exp Allergy       Date:  2004-05       Impact factor: 5.018

6.  Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines.

Authors:  S Majumder; L Z Zhou; P Chaturvedi; G Babcock; S Aras; R M Ransohoff
Journal:  J Neurosci Res       Date:  1998-10-15       Impact factor: 4.164

Review 7.  A closer look at chemokines and their role in asthmatic responses.

Authors:  Joost J Smit; Nicholas W Lukacs
Journal:  Eur J Pharmacol       Date:  2006-02-07       Impact factor: 4.432

Review 8.  Prostacyclin therapies for the treatment of pulmonary arterial hypertension.

Authors:  M Gomberg-Maitland; H Olschewski
Journal:  Eur Respir J       Date:  2008-04       Impact factor: 16.671

9.  Modulation of cytokine expression in human myeloid dendritic cells by environmental endocrine-disrupting chemicals involves epigenetic regulation.

Authors:  Chih-Hsing Hung; San-Nan Yang; Po-Lin Kuo; Yu-Te Chu; Hui-Wen Chang; Wan-Ju Wei; Shau-Ku Huang; Yuh-Jyh Jong
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

10.  IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations.

Authors:  Peter A B Wark; Fabio Bucchieri; Sebastian L Johnston; Peter G Gibson; Lynnsey Hamilton; Joanna Mimica; Giovanni Zummo; Stephen T Holgate; John Attia; Ammarin Thakkinstian; Donna E Davies
Journal:  J Allergy Clin Immunol       Date:  2007-07-12       Impact factor: 10.793

View more
  15 in total

1.  Iloprost for asthma.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2011-01       Impact factor: 4.599

2.  Effect of prostaglandin I2 analogs on monocyte chemoattractant protein-1 in human monocyte and macrophage.

Authors:  Ming-Kai Tsai; Chong-Chao Hsieh; Hsuan-Fu Kuo; Min-Sheng Lee; Ming-Yii Huang; Chang-Hung Kuo; Chih-Hsing Hung
Journal:  Clin Exp Med       Date:  2014-08-26       Impact factor: 3.984

3.  15-Lipoxygenases regulate the production of chemokines in human lung macrophages.

Authors:  C Abrial; S Grassin-Delyle; H Salvator; M Brollo; E Naline; P Devillier
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

Review 4.  PGI2 as a regulator of CD4+ subset differentiation and function.

Authors:  Madison G Boswell; Weisong Zhou; Dawn C Newcomb; R Stokes Peebles
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-12       Impact factor: 3.072

Review 5.  Epigenetics, asthma, and allergic diseases: a review of the latest advancements.

Authors:  Stephanie Lovinsky-Desir; Rachel L Miller
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

6.  Effect of prostaglandin I2 analogs on cytokine expression in human myeloid dendritic cells via epigenetic regulation.

Authors:  Chang-Hung Kuo; Ching-Hsiung Lin; San-Nan Yang; Ming-Yii Huang; Hsiu-Lin Chen; Po-Lin Kuo; Ya-Ling Hsu; Shau-Ku Huang; Yuh-Jyh Jong; Wan-Ju Wei; Yi-Pin Chen; Chih-Hsing Hung
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

7.  Prostaglandin I(2) analogues suppress TNF-α expression in human monocytes via mitogen-activated protein kinase pathway.

Authors:  Wei-Li Wang; Chang-Hung Kuo; Yu-Te Chu; Ching-Hua Huang; Ka-Pan Lam; Shau-Ku Huang; Yuh-Jyh Jong; Yu-Ting Kuo; Chih-Hsing Hung
Journal:  Inflamm Res       Date:  2011-03-13       Impact factor: 4.575

8.  Chryseomonas luteola bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy.

Authors:  A Y Wen; I K Weiss; R B Kelly
Journal:  Infection       Date:  2013-01-18       Impact factor: 3.553

9.  Prostaglandin I2 Suppresses Proinflammatory Chemokine Expression, CD4 T Cell Activation, and STAT6-Independent Allergic Lung Inflammation.

Authors:  Weisong Zhou; Jian Zhang; Kasia Goleniewska; Daniel E Dulek; Shinji Toki; Dawn C Newcomb; Jacqueline Y Cephus; Robert D Collins; Pingsheng Wu; Mark R Boothby; R Stokes Peebles
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

Review 10.  PGI2 as a regulator of inflammatory diseases.

Authors:  Stacy L Dorris; R Stokes Peebles
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.